Integral Derivatives’s Elevance Health ELV Stock Holding History

Integral Derivatives’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,200	Closed	-$2.29M	–	765
2017 Q4	$2.29M	Sell	10,200 -300	-3%	-$63.9K	0.05%	261
2017 Q3	$1.99M	Buy	10,500 +4,800	+84%	+$914K	0.04%	313
2017 Q2	$1.07M	Hold	5,700	–	–	0.02%	465
2017 Q1	$943K	Buy	+5,700	New	+$907K	0.02%	541
2015 Q4	–	Sell	-2,800	Closed	-$392K	–	1105
2015 Q3	$392K	Buy	+2,800	New	+$421K	0.01%	778
2015 Q1	–	Sell	-16,500	Closed	-$2.07M	–	1158
2014 Q4	$2.07M	Hold	16,500	–	–	0.04%	420
2014 Q3	$1.97M	Sell	16,500 -5,100	-24%	-$585K	0.04%	470
2014 Q2	$2.32M	Buy	21,600 +5,100	+31%	+$525K	0.04%	364
2014 Q1	$1.64M	Buy	16,500 +14,300	+650%	+$1.29M	0.03%	486
2013 Q4	$203K	Buy	+2,200	New	+$195K	﹤0.01%	1351

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integral Derivatives's ELV Position: Q1 2018 in Review

Integral Derivatives sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 8,620 shares — an estimated $2.02M sold.

Integral Derivatives first reported a position in ELV in Q3 2015 and held it in 3 quarters. The position peaked at $1.94M in Q4 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

Integral Derivatives reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 8,620 Elevance Health shares in Q1 2018, an estimated $2.02M.
Integral Derivatives first reported a position in Elevance Health in Q3 2015 and held it in 3 quarters.
Integral Derivatives's Elevance Health position peaked at $1.94M in Q4 2017.
922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.